Drug Abuse Testing Market Overview:
The global drug abuse testing market was valued at $6,244 million in 2017 and is expected to reach $11,833 million by 2025, registering a CAGR of 8.2% from 2018 to 2025.
A drug test is primarily performed to confirm the presence of one or more illegal or prescription drugs in a person’s urine, blood, saliva, hair, or sweat. The test is performed by using the samples such as urine, hair, blood, saliva, and others. Among these urine sample is the most widely preferred owing to the advantages it offers, such as lower test cost, availability of more sample, and availability of point-of-care tests. Drug testing offers a critical adjunct to clinical care and substance use. The most often tested drugs include marijuana, opioids, cocaine, morphine, and others. Drug tests are increasingly being adopted by sports organizations, employers, forensic purposes, and several other applications.
The surge in consumption of alcohol and illicit drugs across the globe is one of the major drivers for the drug testing market. In addition, technological advancements toward the development of more accurate and precise testing devices and stringent government regulations mandating drug abuse monitoring further boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market. On the contrary, emerging markets such as the Asia-Pacific and LAMEA, provide lucrative growth opportunities for the market.
The global drug abuse testing market is segmented based on products & services, sample type, end user, and region. Based on products & services, it is divided into equipment, rapid testing devices (RTD), consumables, and laboratory services. Based on equipment, it is further categorized into immunoassay analyzers, chromatography instruments, and breath analyzers. Based on RTD, it is bifurcated into urine testing devices and oral fluid/saliva testing devices. Based on consumables, it is divided into assay kits, sample collection cups, calibrators & controls, and other consumables. Based on sample type, the market is divided into urine sample, breath sample, oral fluid sample, hair sample, and others.
Based on end user, it is segmented into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, pain management centers, and personal users. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for drug abuse testing market:
The study provides an in-depth analysis of the global drug abuse testing market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Drug Abuse Testing Key Market Segments:
By Product & Services
Analyzers
Consumables
Rapid Testing Devices
Laboratory Services
By Sample Type
Urine
Oral Fluid (Saliva)
Hair
Breath
Others
By End User
Workplaces & Schools
Criminal Justice Systems and Law Enforcement Agencies
Research Laboratories
Hospitals
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Turkey
Rest of LAMEA
Key Market Players:
Drägerwerk AG & Co
Abbott Laboratories
Hoffmann-La Roche AG
Bio Rad Laboratories, Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Danaher Corporation
Quest Diagnostics Incorporated
Express Diagnostics International Inc.
Laboratory Corporation of America Holdings
The other players in the value chain include (profiles not included in the report):
OraSure
Alfa Scientific Designs
Lifeloc
MPD, Inc
Premier Biotech
Shimadzu
Psychemedics
SureHire
CannAmm
Omega Laboratories
The global drug abuse testing market was valued at $6,244 million in 2017 and is expected to reach $11,833 million by 2025, registering a CAGR of 8.2% from 2018 to 2025.
A drug test is primarily performed to confirm the presence of one or more illegal or prescription drugs in a person’s urine, blood, saliva, hair, or sweat. The test is performed by using the samples such as urine, hair, blood, saliva, and others. Among these urine sample is the most widely preferred owing to the advantages it offers, such as lower test cost, availability of more sample, and availability of point-of-care tests. Drug testing offers a critical adjunct to clinical care and substance use. The most often tested drugs include marijuana, opioids, cocaine, morphine, and others. Drug tests are increasingly being adopted by sports organizations, employers, forensic purposes, and several other applications.
The surge in consumption of alcohol and illicit drugs across the globe is one of the major drivers for the drug testing market. In addition, technological advancements toward the development of more accurate and precise testing devices and stringent government regulations mandating drug abuse monitoring further boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market. On the contrary, emerging markets such as the Asia-Pacific and LAMEA, provide lucrative growth opportunities for the market.
The global drug abuse testing market is segmented based on products & services, sample type, end user, and region. Based on products & services, it is divided into equipment, rapid testing devices (RTD), consumables, and laboratory services. Based on equipment, it is further categorized into immunoassay analyzers, chromatography instruments, and breath analyzers. Based on RTD, it is bifurcated into urine testing devices and oral fluid/saliva testing devices. Based on consumables, it is divided into assay kits, sample collection cups, calibrators & controls, and other consumables. Based on sample type, the market is divided into urine sample, breath sample, oral fluid sample, hair sample, and others.
Based on end user, it is segmented into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, pain management centers, and personal users. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for drug abuse testing market:
The study provides an in-depth analysis of the global drug abuse testing market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Drug Abuse Testing Key Market Segments:
By Product & Services
Analyzers
Consumables
Rapid Testing Devices
Laboratory Services
By Sample Type
Urine
Oral Fluid (Saliva)
Hair
Breath
Others
By End User
Workplaces & Schools
Criminal Justice Systems and Law Enforcement Agencies
Research Laboratories
Hospitals
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Turkey
Rest of LAMEA
Key Market Players:
Drägerwerk AG & Co
Abbott Laboratories
Hoffmann-La Roche AG
Bio Rad Laboratories, Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Danaher Corporation
Quest Diagnostics Incorporated
Express Diagnostics International Inc.
Laboratory Corporation of America Holdings
The other players in the value chain include (profiles not included in the report):
OraSure
Alfa Scientific Designs
Lifeloc
MPD, Inc
Premier Biotech
Shimadzu
Psychemedics
SureHire
CannAmm
Omega Laboratories
Frequently Asked Questions about the Global Drug Abuse Testing Market
What is the estimated value of the Global Drug Abuse Testing Market?
What is the growth rate of the Global Drug Abuse Testing Market?
What is the forecasted size of the Global Drug Abuse Testing Market?
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE
CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE
CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER
CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
Executive Summary
According to this report titled, 'Drug Abuse Testing Market by Product & Service, Sample Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025' the global drug abuse testing market was valued at $6,244 million in 2017, and is projected to reach $11,833 million by 2025, growing at a CAGR of 8.2% from 2018 to 2025.Drug abuse test is a technique used to determine an individuals scope and degree of drug abuse/alcohol consumption. The test is usually performed for drugs of abuse such as marijuana, cocaine, amphetamines, benzodiazepines, PCP, opioids (narcotics), and others. Overuse of prescribed & illicit drugs is the major driver for the drug abuse testing market.
The drug abuse testing market is growing at a significant pace due to surge in incidence of drug abuse across the globe as well as rise in strict guidelines by the government agencies against the use of drug abuse in various fields including sports, schools, workplaces, and others. Further, leading manufacturers are focusing on the technological advancements in drug abuse test devices that contribute to the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market.
The consumables segment by product & service generated the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the use of different consumables for drug testing such as assay kits, sample collection cups, calibrators and controls, and others.
Based on sample type, the market is classified into urine, oral fluid (saliva), breath, hair, and other samples. Urine sample generated the highest revenue among all the samples. Urine testing has been well established in forensic toxicology with added versatility and easier sample collection.
Key Findings of the Drug Abuse Testing Market:
Based on product, the consumables segment dominated the global drug abuse testing market in 2017 and is expected to maintain this trend during the forecast period.
Based on sample type, the hair sample is expected to register the highest CAGR of 12.0% from 2018 to 2025.
Based on end user, the criminal justice systems and law enforcement agencies segment is expected to register the highest CAGR of 10.2% from 2018 to 2025.
U.S. generated the highest revenue in the global drug abuse testing market in 2017, accounting for more than half of the market in North America.
Asia-Pacific is anticipated to experience rapid growth during the forecast period.
North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers and surge in R&D expenditure for the development of more precise and accurate drug abuse testing devices. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase in awareness regarding the use of drug abuse tests devices by the employers and law enforcement agencies.
The report provides an extensive competitive analysis and profiles of the key market players, such as Drgerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. The other key players included in the value chain analysis (but not included in the report) are OraSure, Alfa Scientific Designs, Lifeloc, MPD, Inc., Premier Biotech, Shimadzu, Psychemedics, SureHire, CannAmm, and Omega Laboratories.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
